Inventor · disambiguated record
Cornelis Joseph Maria Melief
Also filed as: MELIEF CORNELIS J M · MELIEF CORNELIS JOHANNES MARIA · MELIEF CORNELIS JOSEPH MARIA
11 granted patents·2 pending applications·124 citations·filing 1992–2019
89Inventor score
Files withLUDWIG INST CANCER RES3UNIV LEIDEN3ISA PHARMACEUTICALS B V2HERBERT-FRANSEN MARIEKE FERNANDE1OSSENDORP FERDINAND ANTONIUS1
Top patents by PatentIndex Score
13 records- 0181US9522962B2Peptides, conjugates and method for increasing immunogenicity of a vaccineOSSENDORP FERDINAND ANTONIUS·Filed 2011·Granted Dec 20, 2016·7 cites·16 claims
- 0273US5554724AIsolated tumor rejection antigen precursor MAGE-2 derived peptides, and uses thereofUNIV LEIDEN·Filed 1994·Granted Sep 10, 1996·36 cites·4 claims
- 0370US6682731B1Isolated peptides derived from mage tumor rejection antigen precursors which complex with HLA-A2 moleculesLUDWIG INST CANCER RES·Filed 2000·Granted Jan 27, 2004·3 cites·2 claims
- 0467US5731160AInduction of antigen specific T-lymphocyte responses by stimulation with peptide loaded MHC class I molecules on antigen processing defective mammalian cell linesUNIV LEIDEN·Filed 1992·Granted Mar 24, 1998·35 cites·10 claims
- 0561US5679641APeptides of human P53 protein for use in human T cell response inducing compositions, and human P53 protein-specific cytotoxic t-lymphocytesUNIV LEIDEN·Filed 1993·Granted Oct 21, 1997·28 cites·7 claims
- 0661US2011311525A1Delivery of a cd40 agonist to a tumor draining lymph node of a subjectHERBERT-FRANSEN MARIEKE FERNANDE·Filed 2009·Application pending·0 cites
- 0760US6063900AIsolated tumor rejection antigen precursor MAGE-2 derived peptides, and uses thereofLUDWIG INST CANCER RES·Filed 1996·Granted May 16, 2000·9 cites·9 claims
- 0856US10898567B2Synthetic long peptides (SLP) for therapeutic vaccination against Hepatitis B virus infectionISA PHARMACEUTICALS B V·Filed 2019·Granted Jan 26, 2021·0 cites·19 claims
- 0953US9393219B2Monophenols and benzenediols sensitization of immune system against haptenized melanoma antigensWESTERHOF WIETE·Filed 2012·Granted Jul 19, 2016·0 cites·4 claims
- 1036US10376576B2Synthetic long peptides (SLP) for therapeutic vaccination against hepatitis B virus infectionISA PHARMACEUTICALS B V·Filed 2015·Granted Aug 13, 2019·0 cites·25 claims
- 1135US6147187AIsolated tumor rejection antigen precursor mage-2 derived peptides and uses thereofLUDWIG INST CANCER RES·Filed 1998·Granted Nov 14, 2000·4 cites·9 claims
- 1234US7364741B1Peptides of human Papilloma virus for use in human T cell response inducing compositionsPHARMEXA INC·Filed 1993·Granted Apr 29, 2008·2 cites·12 claims
- 1334US2003186355A1Methods for selecting and producing t cell peptide epitopes and vaccines incorporating said selected epitopesFiled 2001·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Cornelis Joseph Maria Melief files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →